Cement board maker’s $1.4B acquisition of Gilead Sciences boosts stock value: report

Cement boards are used to protect against infections, and a major new company is getting in on the action with its acquisition of a cement-making company.Gileads, the drugmaker that is also a maker of insulin and is seeking a vaccine for the hepatitis C virus, said Thursday that it would pay $1 billion for cement board maker Cement-Bartlett.It will also […]

Tags: Categories: Sustainability
View the post